ArticleFrontiers in pharmacology2022

Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study.

Caiyun Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.